And really, the headline number of $700k quarterly loss isn't that bad, considering that CGS reduced payables by an extra $500k this quarter compared to last, plus a $1.25m increase in receivables.
Completely timing differences in my opinion. Big news here is the consistent revenue growth. If the market overlooks that for the headline cash outflow number then this undiscovered gem just remains cheaper for the rest of us!
- Forums
- ASX - By Stock
- CGS
- Ann: Business Update and Appendix 4C
CGS
cogstate ltd
Add to My Watchlist
0.61%
!
$1.66

Ann: Business Update and Appendix 4C, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.66 |
Change
0.010(0.61%) |
Mkt cap ! $280.4M |
Open | High | Low | Value | Volume |
$1.65 | $1.68 | $1.62 | $34.96K | 21.09K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 621 | $1.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.68 | 2298 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 621 | 1.610 |
7 | 7699 | 1.600 |
3 | 10722 | 1.575 |
1 | 829 | 1.570 |
1 | 1500 | 1.560 |
Price($) | Vol. | No. |
---|---|---|
1.710 | 10000 | 1 |
1.740 | 1000 | 1 |
1.750 | 1758 | 1 |
1.790 | 1789 | 1 |
1.800 | 9300 | 3 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
CGS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online